William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Starts Ethos Technologies (LIFE) at Outperform
-
Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold
-
William Blair Starts Zimmer Biomet (ZBH) at Market Perform
-
William Blair Starts Stryker (SYK) at Outperform
-
Harbor Compliance Secures Majority Growth Investment from Bregal Sagemount and Appoints New CEO
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Daily disposable contact lenses set to power market rebound in 2026
-
Immunic closes $200 million private placement financing
-
Immunic Announces Closing of Oversubscribed Private Placement Financing
-
Blackstone to acquire Champions Group home services provider
-
Blackstone Announces Agreement to Acquire Champions Group
-
William Blair Upgrades Neumora Therapeutics (NMRA) to Outperform
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Dec 31
-
Immunic raises up to $400 million in oversubscribed private placement
-
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
-
Evommune raises $125 million in private placement
-
Evommune Announces $125 Million Private Placement
-
William Blair Reiterates Outperform Rating on CBRE Group (CBRE)
-
William Blair Reiterates Outperform Rating on ViaSat (VSAT)
-
William Blair Reiterates Outperform Rating on HubSpot Inc (HUBS)
-
William Blair Upgrades Fastly Inc. (FSLY) to Outperform
-
Carlson Private Capital PartnersCelebrates Milestones: New Senior Hire, New Platform Investment, and Significant Strategic Acquisition for CPC Portfolio Company, Quantum Design
-
Healthcare Services Group Reports Full Year and Fourth Quarter Results
-
William Blair Reiterates Outperform Rating on Centrus Energy Corp. (LEU)
-
William Blair Upgrades Nektar Therapeutics (NKTR) to Outperform
-
William Blair Starts MillerKnoll (MLKN) at Outperform
-
William Blair Starts Tyra Biosciences (TYRA) at Outperform
-
nLIGHT raises additional $26 million as underwriters exercise option
-
nLIGHT, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Form SCHEDULE 13G DIEBOLD NIXDORF, Inc Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G Revolve Group, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SCHEDULE 13G/A Twist Bioscience Corp Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
